Testing for Coronary Artery Disease - PowerPoint PPT Presentation

About This Presentation
Title:

Testing for Coronary Artery Disease

Description:

Testing for Coronary Artery Disease John L. Tan, MD, PhD North Texas Heart Center Presbyterian Hospital of Dallas Rate of Myocardial Infarctions Lifetime Risk of CAD ... – PowerPoint PPT presentation

Number of Views:127
Avg rating:3.0/5.0
Slides: 71
Provided by: Khanh9
Category:

less

Transcript and Presenter's Notes

Title: Testing for Coronary Artery Disease


1
Testing for Coronary Artery Disease
  • John L. Tan, MD, PhD
  • North Texas Heart Center
  • Presbyterian Hospital of Dallas

2
Cardiovascular Disease Mortality Trends United
States 1979-2002
Deaths in Thousands
Year
Source CDC/NCHS.
3
Leading Causes of Death United States 2002
Deaths in Thousands
A Total CVD (Preliminary) B Cancer C
Accidents
D Chronic Lower Respiratory Diseases E Diabetes
Mellitus F Alzheimers Disease
Source CDC/NCHS
4
Rate of Myocardial Infarctions
Number (Annual)
Myocardial Infarction
Heart and Stroke Statistical Update. 2002.
5
Lifetime Risk of CAD
Lifetime Risk ()
Age (Years)
Lloyd-Jones, DM et al. 1999. Lancet. 35389
6
Growing Prevalence of CAD
  • Larger pool
  • Population is growing older
  • Greater Risks
  • Increasing incidence of
  • Obesity
  • Diabetes
  • Metabolic Syndrome
  • Hypertension

7
Who Are at Risk?
How Can We Identify Them?
8
The Framingham Score for Risk Prediction
Risk Low lt10 Intermediate 10-20 High
gt20
Greenland and Gaziano, NEJM, 2003
9
Framingham Risk Score
  • 50 year-old man
  • Total cholesterol 240
  • Non-smoker
  • HDL 40
  • SBP 140 mm Hg
  • Framingham Risk Score
  • 10-year Risk

6
4
0
1
1
12
10 (Intermediate)
10
Framingham Risk Score
  • 45 year-old woman
  • Total cholesterol 240
  • Smoker
  • HDL 50
  • SBP 140 mm Hg
  • Framingham Risk Score
  • 10-year Risk

3
8
7
0
3
21
14 (Intermediate)
11
Limitations of the Framingham Risk Score
  • Family History of Premature CAD
  • CRP Levels
  • Metabolic Syndrome

12
Elevated hs-CRP as an Independent Risk Factor
Ridker et al, NEJM, 2004
13
Mortality Rates in Adults with Metabolic
Syndrome NHANES II 1976-80 Follow-up Study
13 years average follow-up.
Source Circulation 20041101245-50.
14
Initial Assessment
  • Framingham Risk Score
  • Family History of Premature CAD
  • CRP Levels
  • Presence of the Metabolic Syndrome
  • (High triglycerides, Glucose Intolerance,
    Central Adiposity)
  • Presence of Diabetes

15
Now What?
Fear of God
Modify Risk Factors
Further Risk Stratify
16
Available Tests to Detect CAD
  • Stress ECG
  • Stress Imaging Study
  • Ultra-fast CT (EBCT)
  • CT Angiography
  • Coronary Angiography

17
Initial Considerations
  • Symptomatic versus Asymptomatic
  • Diagnosis versus Prognosis
  • Assessment of Risk for CV mortality
  • Physiological/Functional versus Anatomical

18
Patients with Symptoms
19
Clinical Classification of Chest Pain
Typical Angina (definite)
(1) Substernal chest discomfort with a
characteristic quality and duration that is (2)
provoked by exertion or emotional stress and (3)
relieved by rest or nitroglycerin
Atypical Angina (probable)
Meets 2 of the above characteristics
Noncardiac Chest Pain
Meets one or none of the typical angina
characteristics
ACC/AHA ACP-ASIM Guidelines for Chronic Stable
Angina, 1999
20
Pretest Likelihood of CAD in Symptomatic
Patients Percent with significant CAD on
catheterization
Nonanginal Chest Pain
Atypical Angina
Typical Angina
Age, yrs
Men
Men
Women
Men
Women
Women
30-39 4 2 34 12 76 26 40-49 13 3 51 22 87 55 5
0-59 20 7 65 31 93 73 60-69 27 14 72 51 94 86
ACC/AHA ACP-ASIM Guidelines for Chronic Stable
Angina, 1999
21
Kaplan-Meier Survival in Risk Stratified Patients
Shaw, et al, AJC, 2000
22
Exercise Testing
23
Clinically Useful Bench Marks of Exercise Capacity
  • 1 MET Basal activity level (3.5 ml
    O2 comsumed/Kg/min
  • lt 5 METs Associated with a poor prognosis
    in patients lt65 y/o
  • 5 METs Marks the limit of ADLs, usual
    limit immediate post MI
  • 10 METs Considered average level of
    fitness
  • In patients with angina, no
    mortality benefit CABG vs
  • medical Rx
  • 13 METs Good prognosis in spite of any
    abnormal exercise test
  • response
  • 18 METs Aerobic master athelete
  • 22 METs Achieved by well-trained
    competitive atheletes

24
Four-year Mortality Rates with Abnormal ETT
Effects of Exercise Capacity
4-year Mortality Rates ()
Weiner, et al, JACC, 1984
25
Exercise Parameters Associated with Advanced CAD
or Poor Prognosis
  • 1. Duration of ETT lt6.5 METS (lt5 METS for
    women)
  • 2. Exercise HR lt120 bpm off b-blockers
  • 3. Ischemic ST segment change at HR lt120 bpm or
    lt6.5
  • METS
  • 4. ST segment depression gt2 mm, especially in
    multiple
  • leads
  • 5. ST segment depression for gt6 min in
    recovery
  • 6. Decrease in BP during exercise

26
Probability of Significant Disease Across Duke TM
Scores
Alexander, et al, JACC, 1998
27
Survival According to Risk Groups Based on Duke
TM Scores
Risk Group, Score of Total Survival
Mortality,
Low (5 or greater) 62 0.99 0.25 Moderate
(-10 to 4) 34 0.95 1.25 High (-10 or
less) 4 0.79 5.0
Duke TM Score Exercise time - (5 x ST
deviation) - (4 x Treadmill angina)
ACC/AHA ACP-ASIM Guidelines for Chronic Stable
Angina, 1999
28
Meta-analysis of Exercise Testing
Number of
Sensitivity Specificity Predictive
Grouping Studies ()
() Accuracy ()
Standard exercise test 147 68
77 73 Without MI 58
67 72
69 Without workup bias 3
50 90 69 With ST depression
22 69 70
69 Without ST depression 3
67 84 75 With digoxin
15 68 74
71 Without digoxin 9
72 69 70 With LVH
15 68 69 68 Without LVH
10 72 77
74 Overall 70 80
ACC/AHA Guidelines for Exercise Testing, 1997
29
The Ischemic Ladder
Angina
ECG Changes
Systolic Dysfunction
MVO2
Diastolic Dysfunction
Time
30
Stress Imaging
31
Stress Imaging Studies
Stress Modalities
Imaging Modalities
  • Echocardiography
  • Perfusion Imaging
  • Nuclear Scan
  • Thallium Scan
  • Sestamibi Scan
  • Hybrid Scan
  • MRI
  • Exercise
  • Dobutamine
  • Adenosine
  • (Persantine)

32
(No Transcript)
33
(No Transcript)
34
Sensitivity and Specificity of CAD Studies
Procedure Sensitivity () Specificity ()
Exercise Test 68 77 Stress Echo
76 88 SPECT 88 77
Lee and Boucher. 2001. NEJM. 3441840
35
Advantages of Stress Echocardiography
  • 1. Higher specificity
  • 2. Versatility more extensive evaluation of
  • cardiac anatomy and function
  • 3. Greater convenience/efficacy/availability
  • 4. Lower cost

36
Advantages of Stress Myocardial Perfusion Imaging
  • 1. Higher technical success rate
  • 2. Higher sensitivity, especially for
    one-vessel disease
  • 3. Better accuracy in evaluating possible
    ischemia
  • when multiple rest LV wall motion
  • abnormalities are present
  • 4. More extensive published database,
    especially in
  • evaluation of prognosis

37
Patients without Symptoms
High Grade Stenoses
Diabetics
Non-flow Limiting Disease
38
Abnormal Perfusion Scans in Asymptomatic Diabetics
Abnormal Stress Perfusion Scan
A DIAD Study (Wackers et al. 2004. Diabetes
Care. 271954) B Rajagopalan et al.
(Rajagopalan et al. 2005. J Am Coll Cardiol.
4543) C Cedars-Sinai Group (Zellweger et al.
2004. Eur Heart. 25543)
39
Yield of High-Risk Scans in Asymtomatic Diabetics
Subgroup
High-risk Scans
  • Q waves on ECG 43
  • Abnormal ECG 26
  • Peripheral Vascular Disease 28
  • LDL gt100 mg/dl 20
  • Two or more risk factors 17

Rajagopalan et al. 2005. J Am Coll Cardiol.
4543
40
Screening of CAD ADA Recommendations
  • In asymptomatic diabetic patients with
  • Abnormal resting ECG (MI or ischemia)
  • Peripheral vascular disease
  • Two or more additional CAD risk factors

41
Patients without Symptoms
Mild CAD Not Detectable by Stress Testing
42
Myocardial Infarctions and Plaque Severity
Burke et al. NEJM. 1997. 3361276
Myocardial Infarctions ()
2/3
1/6
1/6
Plaque Severity
43
Outcomes with Mild CAD
TIMI Trials Meta-analysis
Death or Non-fatal MI
1-year follow-up
44
5-Year Incidence of Coronary Death

n763
n274
n377
MONICA Belgian Substudy
Stenosis by Angiography
45
Available Tests to Detect CAD
  • Stress ECG
  • Stress Imaging Study
  • Ultra-fast CT (EBCT)
  • CT Angiography
  • Coronary Angiography

46
Coronary Calcium Scoring
Greenland and Gaziano, NEJM, 2003
47
Incremental Value of Coronary Calcium Scoring to
Risk Assessment
Greenland et al, JAMA, 2004
48
Sensitivity and Specificity of CAD Studies
Procedure Sensitivity () Specificity ()
Exercise Test 68 77 Stress Echo
76 88 SPECT 88 77 EBCT
80-90 40-50
49
Population versus Individual Risk
Treating the Herd
50
Multi-Detector Computer Tomography (MDCT)
51
Multi-Detector Computed Tomography (MDCT)
  • Increased slices per gantry rotation
  • (currently 64 slices)
  • Faster gantry speed (330 ms/rotation)
  • resulting in
  • better spatial resolution (0.4 mm)
  • better temporal resolution (165 ms)

52
MDCT Capabilities
53
Coronary Angiography with MDCT
Fuster V, et al. J Am Coll Cardiol. 2005.
461209
54
Coronary Angiography with MDCT
Raff, et al. J Am Coll Cardiol. 2005. 46552
55
64-Slice CT Angiography Per Segment Analysis
Sensitivity () Specificity () PPV ()
NPV ()
Leschka, et al 94
97 87 99 Leber,
et al 80 97 NR
NR Raff, et al 86
95 66 98 Pugliese,
et al 99 96 78
99 Mollet, et al 99
95 76 99
NR Not Reported
Leschka, et al. Eur Heart J. 2005. 261482
Leber, etl al. J Am Coll Cardiol 2005.
46147 Raff, et al. J Am Coll Cardiol. 2005.
46552 Pugliese, et al. Eur Radiol. 2005 161
Mollet, et al. Circulation 2005. 112(15)2318
56
64-Slice CT Angiography Per Patient Analysis
Sensitivity () Specificity () PPV ()
NPV ()
Raff, et al 86
95 66 98 Pugliese, et
al 100 90 96
100
Raff, et al. J Am Coll Cardiol. 2005. 46552
Pugliese, et al. Eur Radiol. 2005 161
57
Detection of Soft Plaque by CT Angiography
Fuster V, et al. J Am Coll Cardiol. 2005.
461209
58
Indications for MDCT Angiography of the Heart
  1. Facilitation of the diagnostic cardiac evaluation
    of a patient with chest pain syndrome (e.g. chest
    pains, anginal equivalent, angina). Depending on
    the clinical presentation, the MDCT for coronary
    artery evaluation may precede a perfusion stress
    test, or it may be used to clarify a perfusion
    stress test that is non-diagnostic, equivocal, or
    is inadequate in explaining the patients
    symptoms.
  2. Facilitation of the management decision of a
    symptomatic patient with known coronary artery
    disease. (e.g. post-stent, post CABG) when the
    results of the MDCT may guide the decision for
    repeat invasive intervention.
  3. Assessment of suspected congenital anomalies of
    coronary circulation or great vessels.

59
Radiation Exposure of CAD Studies
Dose (mSv)
Background (per year) 3.5 Chest
X-ray 0.1 CT of Chest 5-7 Procedure
EBCT 1 Perfusion Imaging 10 CT
Angiography 10 Coronary Angiography 2-3
Conti, CR. Clin. Cardiol. 2005. 28450 Morin
RL, et. al. Circulation. 2003. 107917
60
Sensitivity and Specificity of CAD Studies
Procedure Sensitivity () Specificity ()
Exercise Test 68 77 Stress Echo
76 88 SPECT 88 77 (40-60 of patients
have attenuation defects) EBCT 80-90
40-50 MDCT (per
patient analysis) 16-Slice 85-100
75-86 64-Slice
86-100 90-95
61
Invasive Coronary Angiography
  • 25 of angiograms performed annually in the US
    are normal
  • 8 million angiograms are performed annually in
    the US at a cost of 4,000 per procedure

62
Invasive Coronary Angiography
  • Therefore, there are 2 million angiograms
    performed annually on patients with normal
    coronary arteries
  • These procedures expose patients to the inherent
    risks of invasive coronary angiography at a cost
    of 4 billion per year

63
Summary
  • The incidence and prevalence of CAD is
  • growing due to aging of the population
  • and to increases in risk factors.
  • Global clinical assessment, CRP levels,
  • and calcium scoring may help to further
  • stratify individual risks.

64
Summary
  • Stress testing currently remains the
  • standard for assessing symptoms.
  • Although a negative stress study most
  • likely excludes the presence of flow-
  • limiting disease (stenosis of gt70), it
  • does not exclude the presence of mild to
  • moderate disease.

65
Summary
  • Mild to moderate disease still confers an
  • increase in coronary deaths and
  • infarctions.
  • Invasive coronary arteriography has been
  • the only method of identifying patients
  • with mild to moderate disease up to now.

66
Summary
  • CT angiography will allow for the non-
  • invasive identification of at-risk patients
  • as having (or not having) underlying
  • coronary atherosclerosis.

67
Summary
  • Exercise Test
  • Probable more than we do
  • Stress Echocardiogram
  • Lower pre-test probablility population
  • Valvular or other structural heart disease

68
Summary
  • Stress Perfusion Scan
  • Higher pre-test probability population
  • Cardiac MRI
  • When above unhelpful and expertise is available

69
Summary
  • Ultra-fast CT (EBCT)
  • No role in symptomatic patients
  • CT Angiography
  • Will play larger role with ability to image
    coronaries (Triple Rule Out)
  • Coronary Angiography
  • When stress testing is potentially dangerous

70
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com